A detailed history of Geode Capital Management, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 330,575 shares of ANIX stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
330,575
Previous 320,148 3.26%
Holding current value
$1.2 Million
Previous $998,000 26.85%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$2.21 - $3.35 $23,043 - $34,930
10,427 Added 3.26%
330,575 $730,000
Q1 2024

May 13, 2024

BUY
$3.08 - $5.02 $23,642 - $38,533
7,676 Added 2.46%
320,148 $998,000
Q4 2023

Feb 13, 2024

BUY
$2.85 - $4.19 $36,554 - $53,740
12,826 Added 4.28%
312,472 $1.21 Million
Q3 2023

Nov 13, 2023

SELL
$2.97 - $3.87 $10,014 - $13,049
-3,372 Reduced 1.11%
299,646 $979,000
Q2 2023

Aug 11, 2023

BUY
$3.0 - $5.97 $86,187 - $171,512
28,729 Added 10.47%
303,018 $969,000
Q4 2022

Feb 13, 2023

BUY
$3.78 - $5.81 $13,706 - $21,067
3,626 Added 1.34%
274,289 $1.17 Million
Q3 2022

Nov 14, 2022

BUY
$2.81 - $6.15 $1,854 - $4,059
660 Added 0.24%
270,663 $1.33 Million
Q2 2022

Aug 12, 2022

BUY
$2.55 - $4.1 $1,986 - $3,193
779 Added 0.29%
270,003 $826,000
Q1 2022

May 13, 2022

BUY
$2.5 - $3.42 $13,182 - $18,033
5,273 Added 2.0%
269,224 $737,000
Q3 2021

Nov 12, 2021

BUY
$3.57 - $5.6 $179,024 - $280,823
50,147 Added 23.45%
263,951 $1.26 Million
Q2 2021

Aug 13, 2021

BUY
$3.46 - $4.92 $155,167 - $220,642
44,846 Added 26.54%
213,804 $829,000
Q1 2021

May 12, 2021

BUY
$3.27 - $7.14 $186,890 - $408,072
57,153 Added 51.12%
168,958 $790,000
Q4 2020

Feb 12, 2021

BUY
$1.94 - $3.19 $18,076 - $29,724
9,318 Added 9.09%
111,805 $343,000
Q1 2019

May 14, 2019

BUY
$3.85 - $5.53 $11,865 - $17,043
3,082 Added 3.1%
102,487 $463,000
Q4 2018

Feb 13, 2019

BUY
$3.37 - $6.59 $334,994 - $655,078
99,405 New
99,405 $391,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $111M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.